Positions
63
Top 10 weight
48.1%
Effective holdings
24.1
1 / sum of squared weights
In stocks
99.7%
In bonds
0.0%
Outside the US
31.8%

Asset mix

  • Equity99.7%
  • Cash0.3%

Sectors

87% of stocks classified
  • Health Care80.3%
  • Technology3.6%
  • Financials2.6%

Countries

  • United States67.9%
  • Germany6.4%
  • France5.5%
  • Japan4.9%
  • Denmark4.2%
  • Switzerland3.0%
  • United Kingdom2.6%
  • Canada2.6%
  • China1.8%
  • Iceland0.6%
  • South Korea0.3%

Holdings

#HoldingTypeWeightValueShares / parCountry
1MRNAModerna, Inc. Common StockEquity12.11%$37M187,809US
2TWSTTwist Bioscience Corporation Common StockEquity6.40%$20M128,701US
3IOVAIovance Biotherapeutics, Inc. Common StockEquity4.72%$14M1,084,386US
4GMABGenmab A/S ADSEquity4.18%$13M36,127DK
5RVMDRevolution Medicines, Inc. Common StockEquity3.67%$11M59,680US
6TAKEDA PHARMACEUTICALEquity3.48%$11M289,700JP
7MRKMerck & Co., Inc.Equity3.44%$11M73,760US
8IBRXImmunityBio, Inc. Common StockEquity3.41%$10M1,052,633US
9REGNRegeneron Pharmaceuticals IncEquity3.39%$10M14,015US
10BAYNBAYER AGEquity3.33%$10M213,176DE
11VRTXVertex Pharmaceuticals IncEquity3.28%$10M19,935US
12EXELExelixis IncEquity3.26%$10.0M169,083US
13INCYIncyte Genomics IncEquity3.21%$9.8M87,018US
14CAICaris Life Sciences, Inc. Common StockEquity3.08%$9.4M342,805US
15BNTXBioNTech SE American Depositary ShareEquity3.05%$9.3M101,150DE
16ROPRoper Technologies, Inc. Common StockEquity3.00%$9.2M21,624CH
17IDYAIDEAYA Biosciences, Inc. Common StockEquity2.74%$8.4M232,469US
18GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)Equity2.58%$7.9M343,476GB
19ABCLAbCellera Biologics Inc. Common SharesEquity2.58%$7.9M655,577CA
20SANBanco Santander S.A.Equity2.57%$7.9M98,888FR
21IPNIPSEN SAEquity2.53%$7.7M48,842FR
22RCUSArcus Biosciences, Inc.Equity1.83%$5.6M234,123US
23NVAXNovavax IncEquity1.58%$4.8M437,495US
24ONO PHARMACEUTICALEquity1.45%$4.4M312,500JP
25VIRVir Biotechnology, Inc. Common StockEquity1.36%$4.1M372,599US
26CRSPCRISPR Therapeutics AGEquity1.32%$4.0M80,165US
27NUVBNuvation Bio Inc.Equity1.12%$3.4M690,777US
28JANXJanux Therapeutics, Inc. Common StockEquity0.97%$3.0M159,934US
29PSNLPersonalis, Inc. Common StockEquity0.91%$2.8M173,205US
30KURAKura Oncology, Inc.Equity0.83%$2.5M240,168US
31RIGLRigel Pharmaceuticals Inc. (New)Equity0.80%$2.4M49,959US
32SUNSHINE LAKE PHARMA LTD CLASS HEquity0.76%$2.3M450,100CN
33GENFLEET THERAPEUTICS (SHANGHAI) IEquity0.63%$1.9M534,800CN
34VSTMVerastem, Inc.Equity0.61%$1.9M230,195US
35PACBPacific Biosciences of California, Inc.Equity0.60%$1.8M801,262US
36CRVSCorvus Pharmaceuticals, Inc.Equity0.59%$1.8M176,573US
37ALVOAlvotech Ordinary SharesEquity0.59%$1.8M315,450IS
38XNCRXencor, Inc.Equity0.50%$1.5M62,679US
39NTLAIntellia Therapeutics, IncEquity0.49%$1.5M118,340US
40DNAGinkgo Bioworks Holdings, Inc.Equity0.48%$1.5M130,496US
41VLAVALNEVAEquity0.41%$1.3M449,845FR
42DSGNDesign Therapeutics, Inc. Common StockEquity0.40%$1.2M105,370US
43CTMXCytomX Therapeutics, Inc.Equity0.39%$1.2M484,198US
44SHANGHAI HENLIUS BIOTECH HEquity0.37%$1.1M173,300CN
45OCGNOcugen, Inc. Common StockEquity0.30%$911K932,305US
46ABCLON INCEquity0.28%$844K44,179KR
47XTSLABLK CSH FND TREASURY SL AGENCYCash0.18%$552K552,240US
48PRMEPrime Medicine, Inc. Common StockEquity0.10%$302K84,316US
49JPYLazard Japanese Equity ETFCash0.07%$218K34,420,985JP
50GBPGBP CASHCash0.04%$119K90,166GB
51HBCFTCASH COLLATERAL USD HBCFTCash0.02%$48K48,000GB
52CHFCHF CASHCash0.01%$40K32,986CH
53USDProShares Ultra SemiconductorsCash0.01%$33K33,499US
54DKKDKK CASHCash0.00%$13K88,953DK
55ARCELLX INC CVREquity0.00%$5K73,059US
56HKDAMTD Digital Inc. American Depositary Shares (every five of which represent two Class A Ordinary Shares)Cash0.00%$4K28,855HK
57KRWKRW CASHCash0.00%$3K4,226,072KR
58EUREUR CASHCash0.00%$751670EU
59TWDTWD CASHCash0.00%$1645,229TW
60KRWKRW/USDCash0.00%−$37,778,229US
61OMNIAB INC $12.50 VESTING PrvtEquity0.00%$019,498US
62OMNIAB INC $15.00 VESTING PrvtEquity0.00%$019,498US
63IXCZ6E-MINI HEALTH CARE SECTOR DEC 26Derivative0.00%$05

Find which other funds hold a stock by opening it and choosing "ETFs holding".

Position changes between reports

ActionHoldingWeight beforeWeight afterShares vs flowsBetween reports
ExitRoche Holding AG4.35%——Jan 31, 2026 → Apr 30, 2026 SEC
New positionRoche Holding AG—3.99%—Jan 31, 2026 → Apr 30, 2026 SEC

Share-count changes are measured after removing what creations and redemptions explain.

Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.